glp-1 and gip/glp-1 medications GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Explained: The Mechanisms of GLP-1
Description
Modulating Effect of the PI3-Kinase Inhibitor LY294002 on Cisplatin in Human Pancreatic Cancer Cells
In 1 study, nearly 50% more women discontinued the treatment compared to men, though this difference did not reach significance in this study, which was not powered for sex difference detection (78)
The rats were provided with ad libitum access to food and water and were kept on a 12 h light/12 h dark cycle
Thats the missing piece
